ClinConnect ClinConnect Logo
Search / Trial NCT06650267

Substance Misuse and Family Violence Treatment Fathers

Launched by YALE UNIVERSITY · Oct 17, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Substance Misuse Intimate Partner Violence Domestic Violence Treatment

ClinConnect Summary

This clinical trial is studying a program called Fathers for Change (F4C) to see if it is more effective than Individual Drug Counseling (IDC) in helping fathers who struggle with substance misuse and family violence. The goal is to understand how well F4C helps reduce these issues at the end of treatment and during follow-up visits three and six months later. The researchers believe that improving how fathers manage their emotions might be key to reducing both substance use and family violence.

To be part of this study, fathers need to meet certain criteria. They should have a substance use disorder and have reported family violence in the past year. Additionally, they must have at least one biological child aged 1 to 12 years, with whom they live or visit regularly. Participants will be asked to complete assessments in English and allow researchers to contact the child’s mother for her input. It's important to note that fathers with active protective orders, severe addictions that require detox, or serious mental health issues may not be eligible. Those who join the trial can expect to receive support and treatment aimed at improving their situation while also contributing to important research.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • meet DSM-5 criteria for an SU disorder at the time of assessment at APT or VACHS;
  • report FV within the last 18 months prior to screening (based on self, court, police or child protection reports);
  • have at least one biological child aged 1 to 12 years with whom they live or have at least twice per month in person visits;
  • are able to complete assessments in English; and
  • agree to have their female coparents (mother of the youngest child) contacted for participation of their youngest child. If a participant has more than one child in the age range, the youngest will be the target of assessment and treatment.
  • Exclusion Criteria:
  • an active full/no contact protective order pertaining to their child;
  • physiological addiction to a substance that requires detoxification (such individuals may be re-evaluated following detox);
  • cognitive impairment (a mini mental state score \<25);
  • current untreated psychotic/bipolar disorder;
  • currently suicidal or homicidal based on Brief Symptom Inventory Screening and follow-up on positive responses; or
  • are currently receiving weekly individual therapy for Substance misuse or family violence

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

New Haven, Connecticut, United States

West Haven, Connecticut, United States

Patients applied

0 patients applied

Trial Officials

Carla S Stover, Ph.D.

Principal Investigator

Yale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported